Condition: Diabetes Mellitus Type 2 · Sponsor: University of Aberdeen
Traditional diabetes therapies focus on improving blood sugar control. However, many studies show that this may not be enough. New treatments focusing on weight loss have heralded better results. One of these treatments is Semaglutide and the investigators wish to examine its effects further in this study. The investigators propose to investigate what happens to the fat inside the heart and the leg muscles.
This description comes directly from the study's public registry record.
Alexander Davidson, DM · +441224559573 · alexander.davidson@abdn.ac.uk
Amelia E Rudd, MSc, PhD · 01224559573 · cardiologyresearch@abdn.ac.uk
Always discuss trial participation with your own doctor first.
| Cardiac Research Office, Aberdeen Royal Infirmary | Aberdeen, Aberdeenshire, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07065383